Gajuwaka Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.88 M
- Company Age 23 Year, 23 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Satisfied Charges ₹ 8.50 M
- Revenue Growth -13.17%
- Profit Growth -0.77%
- Ebitda 3.51%
- Net Worth 118.65%
- Total Assets 2.07%
About Gajuwaka Pharmaceuticals
Gajuwaka Pharmaceuticals Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 January 2002 and has a history of 23 years. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.88 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹8.50 M, as per Ministry of Corporate Affairs (MCA) records.
Papa Vegi, Narasimharaju Datlavenkata, Venkata Kethineedi, and Three other members serve as directors at the Company.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239AP2002PTC038342
-
Company No.
038342
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jan 2002
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Gajuwaka Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Papa Vegi
|
Managing Director | 10-Jan-2002 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Narasimharaju Datlavenkata
|
Director | 14-Mar-2014 | Current |
|
Venkata Kethineedi
|
Director | 14-Mar-2014 | Current |
|
Surya Kandregula
|
Director | 14-Mar-2014 | Current |
|
Narayana Kandregula
|
Director | 19-Mar-2018 | Current |
|
Adi Konathala
|
Director | 19-Mar-2018 | Current |
Financial Performance of Gajuwaka Pharmaceuticals.
Gajuwaka Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.17% decrease. The company also saw a slight decrease in profitability, with a 0.77% decrease in profit. The company's net worth Soared by an impressive increase of 118.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gajuwaka Pharmaceuticals?
In 2023, Gajuwaka Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sri Saimadhuri Property Developers LlpPapa Vegi, Narasimharaju Datlavenkata and 1 more are mutual person
-
Steel City Pharmaceuticals Pvt Ltd
Papa Vegi and Narasimharaju Datlavenkata are mutual person
-
Simhagiri Developers Private Limited
Papa Vegi, Narasimharaju Datlavenkata and 1 more are mutual person
-
Saimadhuri Properties Private Limited
Papa Vegi, Narasimharaju Datlavenkata and 2 more are mutual person
-
Saimadhuri Chits (Gajuwaka) Private Limited
Papa Vegi and Narasimharaju Datlavenkata are mutual person
-
Ukkunagar Chits Private Limited
Narasimharaju Datlavenkata is a mutual person
Charges (Loans)
₹4.00 M
₹8.50 M
Charges Breakdown by Lending Institutions
- The Karur Vysya Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2014 | The Karur Vysya Bank Limited | ₹4.00 M | Open |
| 30 Nov 2006 | Indian Overseas Bank | ₹3.50 M | Satisfied |
| 22 Sep 2005 | State Bank Of India | ₹2.50 M | Satisfied |
| 23 Mar 2004 | Indian Overseas Bank | ₹2.50 M | Satisfied |
How Many Employees Work at Gajuwaka Pharmaceuticals?
Unlock and access historical data on people associated with Gajuwaka Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gajuwaka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gajuwaka Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
